open2 vues
India
IndiaBiopharma SHAKTI Mission 2026
A ₹10,000 crore flagship mission announced in Union Budget 2026-27 to position India as a global biotech and biopharma leader. The mission provides grants, equity support, and subsidised loans to biotech startups, MSMEs, and large pharma companies investing in vaccine development, biologics manufacturing, biosimilar production, and genomics research.
Qui peut postuler
Biotech and biopharma companies registered in India, startups registered with DPIIT, MSMEs in pharma/biotech sector, research institutions and academic spin-offs with technology readiness, large pharma companies for manufacturing scale-up in biosimilars, vaccines, cell & gene therapy.Avantages et bénéfices
- Grants
- Equity support
- Subsidised loans
Contacts clés
Sanket Ghogare
Editor
Sources
Liens utilisés par l'IA pour recueillir des informations sur cette subvention.
- schemesinindia.in/central/biopharma-shakti-mission-india ↗
- birac.nic.in/ ↗
- pib.gov.in/PressNoteDetails.aspx?NoteId=157147&ModuleId=3®=3&lang=1 ↗
- economictimes.indiatimes.com/news/economy/policy/budget-2026-union-budget-2026-b… ↗
- static.pib.gov.in/WriteReadData/specificdocs/documents/2026/feb/doc202622776701.… ↗
- www.insightsonindia.com/2026/02/02/biopharma-shakti-initiative/ ↗